
| Serial Number | 97491421 |
| Word Mark | ISOLABS |
| Filing Date | Wednesday, July 6, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, May 6, 2025 |
| Registration Number | 7781670 |
| Registration Date | Tuesday, May 6, 2025 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 18, 2025 |
| Goods and Services | Downloadable computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software applications for designing and developing artificial intelligence, information technology, deep learning technologies, machine learning technologies, and reinforcement learning technologies for predicting protein structure, discovering pharmaceutical drugs, and developing pharmaceutical products; downloadable computer software, computer programs and computer software algorithms for manipulating received or inputted data generated in a virtual space in connection with artificial intelligence methods, natural language processing, natural language understanding, dialog systems, voice and speech recognition and text to speech systems, natural language human-machine interfaces, and predictive assistance technologies; recorded computer programs using artificial intelligence, machine learning, deep learning, and reinforcement learning for software development in the fields of software for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development |
| Pseudo Mark | ISO LABS |
| Goods and Services | Software as a service (SAAS) services featuring software using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; advanced product research, design and development in the field of artificial intelligence; research and development in the fields of artificial intelligence, machine learning, deep learning, and reinforcement learning technologies; technology research in the field of artificial intelligence, machine learning, deep learning, and reinforcement learning for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; computer software development in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; software development consulting in the fields of artificial intelligence, machine learning technologies, deep learning technologies, and reinforcement learning technologies, all for use in protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; providing online, non-downloadable computer software platforms using artificial intelligence, machine learning, deep learning, and reinforcement learning for protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; development and testing of computing methods, computer software algorithms, computer software, and computer hardware; scientific, pharmaceutical, and medical research; scientific research in the field of computer software using artificial intelligence, machine learning, deep learning, and reinforcement learning for medical research, pharmaceutical research, protein structure prediction, pharmaceutical drug discovery, and pharmaceutical product development; product research and development; medical, pharmaceutical, and scientific research in the field of protein structure prediction, pharmaceutical drug discovery, pharmaceutical product development, and computational biology; scientific and technological services, namely, scientific research and technological consulting, scientific research, development and design of computer software and technology in the fields of analytics and data mining, data analysis, data transformation, data visualization, statistical analysis, artificial intelligence, machine learning and virtual reality, science, chemistry, physics, biology, and scientific research; computer aided data analysis for scientific research purposes in the fields of artificial intelligence, machine learning, deep learning, reinforcement learning, building neural networks, data tree search, high performance computing, distributed computing, cloud computing, analytics and data mining, virtual reality, augmented reality, chemistry, physics, biology; computer modelling services; scientific services for the analysis of organic compounds; drug discovery services |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 24, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 24, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Isomorphic Labs Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | London EC2M4AG GB |
| Party Name | Isomorphic Labs Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | London EC2M4RB GB |
| Party Name | Isomorphic Labs Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | London EC4V6JA GB |
| Event Date | Event Description |
| Saturday, July 9, 2022 | NEW APPLICATION ENTERED |
| Tuesday, July 26, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, September 20, 2022 | ASSIGNED TO EXAMINER |
| Wednesday, September 21, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, September 21, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, September 21, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, March 24, 2023 | FINAL REFUSAL WRITTEN |
| Friday, March 24, 2023 | FINAL REFUSAL E-MAILED |
| Friday, March 24, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Saturday, March 25, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, March 25, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, March 25, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, March 25, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, March 25, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, March 31, 2023 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, April 6, 2023 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, April 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 9, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 4, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, December 29, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 2, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, May 9, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Friday, December 29, 2023 | SOU EXTENSION 1 FILED |
| Friday, December 29, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, July 2, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 2, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, July 2, 2024 | SOU EXTENSION 2 FILED |
| Thursday, January 2, 2025 | TEAS PETITION TO AMEND BASIS RECEIVED |
| Friday, April 19, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, April 19, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, April 19, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, January 2, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, January 2, 2025 | SOU EXTENSION 3 FILED |
| Thursday, February 13, 2025 | SOU EXTENSION 3 GRANTED |
| Monday, February 10, 2025 | ASSIGNED TO PETITION STAFF |
| Thursday, February 13, 2025 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Thursday, February 13, 2025 | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED |
| Thursday, February 13, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, February 24, 2025 | NOTICE OF ALLOWANCE CANCELLED |
| Monday, February 24, 2025 | CASE RETURNED TO EXAMINATION |
| Tuesday, March 18, 2025 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 12, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 18, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 6, 2025 | REGISTERED-PRINCIPAL REGISTER |
| Monday, July 14, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 14, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, July 14, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, July 14, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, July 14, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 6, 2025 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |